Primer on multiple sclerosis (notice n° 16278)
| 000 -LEADER | |
|---|---|
| fixed length control field | 01742nam a2200241 u 4500 |
| 001 - CONTROL NUMBER | |
| control field | UNI0000318 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20161124101556.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 131107s2010 XX eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0195369289 (paperback) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780195369281 (paperback) |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | DCLC |
| 040 ## - CATALOGING SOURCE | |
| Modifying agency | IMIST |
| Description conventions | AFNOR |
| 041 1# - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.834 |
| Edition number | 22 |
| 245 #0 - TITLE STATEMENT | |
| Title | Primer on multiple sclerosis |
| Statement of responsibility, etc | Barbara S. Giesser MD. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | [S.l.] |
| Name of publisher, distributor, etc | Oxford University Press, USA |
| Date of publication, distribution, etc | 2010. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 504 p. |
| Dimensions | 26 cm. |
| 500 ## - GENERAL NOTE | |
| General note | Primer on Multiple Sclerosis was developed to provide a comprehensive overview of the clinical and basic science aspects of MS. It is designed to be of practical use to clinical neurologists, and addresses all of the major issues that may occur in the management of persons with MS. The reader is provided with the latest information on the science of MS, including immunology, genetics, epidemiology and pathology, as well as a summary of the newest directions in basic science research. Guidelines for diagnosis and appropriate use of diagnostic modalities are presented. All clinical aspects of MS are discussed, including extensive information on aspects that may be more challenging for the neurologist to manage, such as sleep disorders and pain. Disease modifying therapies, including those that are FDA approved, as well as off label and experimental therapies are discussed. Finally, there are chapters on employment and legal issues, as well as an overview of clinical trials and clinical trial outcome measures, which are helpful in reviewing the scientific literature in these areas. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Multiple sclerosis |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Multiple sclerosis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Giesser, Barbara S. |
| Withdrawn status | Lost status | Damaged status | Not for loan | Permanent Location | Current Location | Date acquired | Inventory number | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| La bibliothèque des Sciences Médicales et Pharmaceutiques | La bibliothèque des Sciences Médicales et Pharmaceutiques | 19787 | 616.834 GIE | 0000000020115 | 11/24/2016 | 11/24/2016 | Livre |
